Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
Detection of a rare BCR–ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS) | PNAS
Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS). - Abstract - Europe PMC
Establishment of a bortezomib-resistant Chinese human multiple myeloma cell line: MMLAL
A novel human multiple myeloma cell line with genetic abnormality of 1q21 gains only and CKS1B overexpression
A) Ultrastructure of NCI-H929 | Download Scientific Diagram
plus dead) labeled
The Expression and Localization of Kappa Myeloma Antigen on Malignant and Normal B cells
Cell adhesion molecule CD166 drives malignant progression and osteolytic disease in multiple myeloma
Establishment and Characterization of a Human Plasma Cell Myeloma Culture Having a Rearranged Cellular myc Proto-oncogene - ScienceDirect
Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1 | Haematologica
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma
A novel xenograft mouse model for testing approaches targeting human kappa light-chain diseases | Gene Therapy
Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma
plus dead) labeled
PDF) Illegitimate WNT signaling promotes proliferation of multiple myeloma cells
WO2015081613A1 - ANTI-HUMAN mIgA ANTIBODIES CAPABLE OF LYSING mIgA-B LYMPHOCYTES AND DECREASING IgA PRODUCTION - Google Patents
Types of Multiple Myeloma | International Myeloma Foundation
Establishment of Five Human Myeloma Cell Lines
Myeloma Explained | Haematology | Oncology | onthewards
Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s
Utility of Intravenous Curcumin Nanodelivery Systems for Improving In Vivo Pharmacokinetics and Anticancer Pharmacodynamics | Molecular Pharmaceutics
Phenotypic and molecular analysis of six human cell lines derived from patients with plasma cell dyscrasia
Heterogeneity and Plasticity of Multiple Myeloma | IntechOpen
